cilostazol
NDC 42291-453, cilostazol, tablet, from AvKARE.
- Product NDC
- 42291-453
- Status
- Listed
- Labeler
- AvKARE
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA077030
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/42291-453 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CILOSTAZOL100 mg/1
Pharmacologic classes
Phosphodiesterase 3 Inhibitor [EPC]; Phosphodiesterase 3 Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 42291-453-60 | 42291045360 | 60 TABLET in 1 BOTTLE (42291-453-60) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/dc7c2c25-36a1-e3fd-e053-2995a90adabc
Use it
Look up 42291-453 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/42291-453 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 42291-453. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.